ABSTRACT: Novel thermally and magnetically dual-responsive mesoporous silica nanoparticles [magnetic mesoporous silica nanospheres (M-MSNs)-poly(N-isopropyl acrylamide) (PNIPAAm)] were developed with magnetic iron oxide (Fe 3 O 4 ) nanoparticles as the core, mesoporous silica nanoparticles as the sandwiched layer, and thermally responsive polymers (PNIPAAm) as the outer shell. M-MSN-PNIPAAm was initially used to control the release of sophoridine. The characteristics of M-MSN-PNIPAAm were investigated by transmission electron microscopy, Fourier transform infrared spectroscopy, X-ray diffraction, thermogravimetry, N 2 adsorption-desorption isotherms, and vibrating specimen magnetometry analyses. The results indicate that the Fe 3 O 4 nanoparticles were incorporated into the M-MSNs, and PNIPAAm was grafted onto the surface of the M-MSNs via precipitation polymerization. The obtained M-MSN-PNIPAAm possessed superparamagnetic characteristics with a high surface area (292.44 m 2 /g), large pore volume (0.246 mL/g), and large mesoporous pore size (2.18 nm). Sophoridine was used as a drug model to investigate the loading and release properties at different temperatures. The results demonstrate that the PNIPAAm layers on the surface of M-MSN-PNIPAAm effectively regulated the uptake and release of sophoridine.
INTRODUCTION
Sophoridine is one of the main alkaloids extracted from Sophora alopecuroides L, 1 and it has a wide range of pharmacological properties, including various strong antitumor activities. 1, 2 However, despite the attractive pharmacological properties of sophoridine, its therapeutic potential is significantly restricted by its wide distribution and rapid elimination in vivo. 3 To overcome these disadvantages, a number nanoparticle and microsphere delivery systems have been developed to encapsulate sophoridine. 4 Nevertheless, these organic carriers often suffer from various disadvantages, including instability in in vivo and in vitro environments, poor controlled release profiles, and common leakages of entrapped components in aqueous media. 4 Thus, the fabrication of novel inorganic-material-based nanocarriers for sophoridine encapsulation may be an effective approach for overcoming such challenges.
Considerable scientific attention has been paid to mesoporous silica nanoparticles (MSNs) because of their superior properties, such as their large surface areas, high pore volumes, tunable pore sizes, and easily modified outer surfaces. [5] [6] [7] [8] MSNs possess good biocompatibility, low toxicity, 9, 10 and excellent physical and chemical stability. MSNs have been widely applied in many fields, including sensors, [11] [12] [13] catalysis, 14, 15 separation, 16 and drug delivery. [17] [18] [19] Numerous types of drugs and bioactive molecules of various sizes, shapes, and functionalities can be hosted in MSNs 20 because their poor channel sizes can be regulated. However, because loaded drugs burst when released from unmodified MSNs, various researchers have focused on exploring intelligent MSNs to overcome this advantage. 21 Intelligent MSNs have been fabricated by the capping of the pores of MSNs with quantum dots, dendrimers, iron oxide, and gold nanoparticles to control drug uptake and release. However, this procedure is irreversible after cap removal, and nanovalve synthesis is a little complex; this limits the application of MSNs in drug-delivery systems. Reversible stimuli-responsive MSNs have recently been developed with pH-responsive, [24] [25] [26] thermally responsive, 27, 28 and photoresponsive polymers. [29] [30] [31] The MSNs modified with such intelligent polymeric materials can control the uptake and release of guest molecules with external stimuli.
Poly(N-isopropyl acrylamide) (PNIPAAm) is a known intelligent polymer that is responsive to the temperature. PNIPAAm has the property of having a soluble (hydrophilic)-insoluble (hydrophobic) transition at a lower critical solution temperature (LCST) of about 32 C in water; 32, 33 it exhibits a coil (soluble) state when the temperature is below the LCST and a collapsed (insoluble) state when the temperature is above the LCST. 34 Moreover, PNIPAAm is also among the smart polymers most commonly used to modify nanoparticles in drug-delivery systems. [35] [36] [37] The thermally responsive behavior of PNIPAAm can be used to design a smart nanoshell on the exterior surface of MSNs; this may be the ideal way to take up and control the release of drugs based on temperature changes.
The control of MSNs coated with PNIPAAm (MSN-PNIPAAm) on the uptake and release of drugs has been established. However, the delivery of drugs by MSN-PNIPAAm to a targeted site 38 is difficult and results in the decreased bioavailability of the drugs. Magnetic iron oxide (Fe 3 O 4 ) nanomaterials have gained considerable attention because of their potential applications in medical fields and magnetically guided drug-delivery vehicles. 31, [39] [40] [41] Hence, the integration of MSN-PNIPAAm with Fe 3 O 4 could selectively deliver drugs to desired organs or tissues inside the body and thereby improve the bioavailability of drugs.
In this study, novel thermally and magnetically dual-responsive mesoporous silica nanoparticles [magnetic mesoporous silica nanospheres (M-MSNs)-PNIPAAm] were delicately prepared. To our knowledge, this successful application of M-MSNPNIPAAm for the controlled uptake and release of sophoridine is the first such study in the field. The physicochemical characteristics of M-MSN-PNIPAAm were investigated systematically. The thermoresponsive behavior of PNIPAAm was used to design a smart nanoshell on the exterior surface of the MMSNs, which could be reversibly switched between open and closed states with temperature changes. The M-MSN-PNIPAAm carrier proved potentially applicable for controlled and targeted drug delivery.
EXPERIMENTAL

Reagents and Materials
Hexadecyltrimethylammonium bromide (CTAB) and 3-(trimethoxysilyl)propyl methacrylate (MPS) were purchased from Sigma-Aldrich (Shanghai, China). Sophoridine (98%), purchased from Sinopharm Chemical Reagent Co., Ltd., was used with recrystallization from petroleum ether. 
Modification of the M-MSNs with MPS
The Fe 3 O 4 @SiO 2 nanoparticles (90 mg) were dissolved in distilled water (160 mL) containing CTAB (1.0 g) and sonicated for 25 min. Afterward, mesitylene (2.5 mL) was added, and the mixture was stirred for 3 h. This was followed by the addition of NH 3 ÁH 2 O (16 mL) and TEOS (3 mL). The mixed system reacted for 6 h at 40
C. The M-MSN-CTAB product was collected by a magnet. M-MSN-CTAB (1.0 g) was dispersed in anhydrous toluene (100 mL), and this was followed by the addition of MPS (10 mL), which was reacted for 24 h at 50 C with nitrogen protection. The M-MSN-CTAB-MPS product was rinsed with anhydrous toluene to remove the unreacted MPS. The M-MSN-CTAB-MPS was placed into an NH 4 NO 3 ethanol solution (200 mL, 10 mg/mL) to remove the CTAB and was refluxed for 6 h at 80 C. The product of M-MSN-MPS was dried in vacuo.
Preparation of M-MSN-PNIPAAm
The M-MSN-MPS was prepared through the seeded precipitation polymerization method. The detailed procedures are as follows. The monomers of NIPAAm (0.424 g) and MBA (22 mg) were dissolved in distilled water (200 mL). Subsequently, M-MSN-MPS (100 mg) was dispersed in the mixed solution by sonication for 20 min. An aqueous solution (5 mL) containing APS (13.4 mg) was added and heated to 70 C under nitrogen protection with stirring for 6 h. The M-MSN-PNIPAAm product was separated with a magnet, washed with distilled water, and dried in vacuo at 50 C.
Loading of M-MSN-PNIPAAm
M-MSN-PNIPAAm (25 mg) was dispersed into a sophoridine aqueous solution (20 mL, 0.1 mmol/L) with shaking for 24 h at 25 and 42 C, respectively. M-MSN-PNIPAAm was separated with a permanent magnet after sophoridine was loaded. The amount of free sophoridine in the supernatant (m f ) was measured by the high-performance liquid chromatography (HPLC) method. The loading efficiency could be calculated as follows:
where m i is the initial amount of sophoridine.
Characterization
The amount of sophoridine was analyzed on a Shimadzu LC-10A system at 25 C with an HPLC pump operating at a flow rate of 1.0 mL/min. The analytical column was a 250 3 4.6 mm 2 , 5-lm C 18 column. The mobile phase was a acetonitrile/ water/acetic acid (65:34:1 v/v/v) mixture. The detection wavelength was 250 nm for sophoridine.
The morphological characteristics of synthetic M-MSNPNIPAAm were observed by transmission electron microscopy (TEM; JEM-2010HR, Japan). The X-ray diffraction (XRD) patterns of the samples were obtained from an X-ray diffractometer (XRD DI System, Bede, United Kingdom). The Fourier transform infrared (FTIR) spectra of the samples were obtained with a Nicolet 5700 FTIR system. Thermogravimetric analysis (TGA) was performed on a synchronous thermogravimetric analyzer (Thermogravimetric/Differential Thermal Analysis (TG/DTA) Pyris Diamond PE). The N 2 adsorption-desorption curves, specific surface area, total pore volume, and average pore size were measured with a fully automatic specific surface instrument (3H-2000PS1, Beishide Instruments, Beijing, China). Vibrating specimen magnetometry (VSM; 7407, Lakeshore) was used to examine the magnetic properties of the samples.
Release Kinetics of M-MSN-PNIPAAm
The sophoridine loaded M-MSN-PNIPAAm (10 mg) was immersed into phosphate buffer (10 mL, 0.01 mol/L, pH 7.4) and placed into water bath at 25 and 42 C with gentle stirring. At predetermined times, the supernatant (1 mL) was withdrawn and replaced with an equal volume of corresponding fresh media to maintain a constant volume. The amount of released sophoridine was determined by HPLC.
To determine the release mechanism of sophoridine from M-MSN-PNIPAAm, the release data were analyzed based on the zero-order, first-order, Higuchi, Hixson-Crowell, and Korsmeyer-Peppas models. The release exponent (n) of the Peppas model was also calculated with the Peppas method. 42, 43 The model equations are as follows:
Higuchi model :
Korsmeyer -Peppas model : ln Q t =Q 1 ð Þ 5nln t1ln k where Q t is the amount of sophoridine released in time t, Q 1 is the total amount of sophoridine in M-MSN-PNIPAAm, k is an incorporating constant, and n is the release exponent indicating the release mechanism.
RESULTS AND DISCUSSION
Fabrication of M-MSN-PNIPAAm
The preparation process for M-MSN-PNIPAAm is illustrated in Scheme 1. Superparamagnetic Fe 3 O 4 nanoparticles were synthesized with the coprecipitation method and were coated with a silica layer to improve the Fe 3 O 4 stability. M-MSN-CTAB was then prepared with CTAB as a surfactant template and mesitylene as a pore-swelling agent. Subsequently, M-MSN-CTAB was modified by MPS, and vinyl groups were grafted onto the exterior surface of the M-MSNs. CTAB was removed through refluxing in NH 4 NO 3 -ethanol solutions to form the pores in the M-MSNs. Finally, the thermoresponsive material of PNIPAAm was grafted onto the surface of the M-MSNs by seeded precipitation polymerization with modified M-MSNs as seeds, APS as the initiator, MBA as the crosslinker, and NIPAAm as The FTIR spectra of the samples are shown in Figure 2 . The absorption band at 573 cm 21 was the stretching vibrations of FeAO for Fe 3 O 4 . After the coating with silica layers, the adsorption peaks at 1081, 958, and 799 cm 21 were assigned to the SiAOASi, SiAOAH, and SiAO groups, respectively; they demonstrated that the Fe 3 O 4 nanoparticles were successfully coated by layers of silica. The absorption peaks at 2924 and 2854 cm 21 were due to the stretching of CAH from CTAB, which disappeared in the spectra of the M-MSNs. This suggested that CTAB was removed completely from M-MSN-CTAB. A new peak appeared at 1701 cm 21 in the spectrum of the M-MSN-MPS. This was the carbonyl group from MPS, and it demonstrated the successful grafting of the vinyl group onto the surface of the M-MSNs compared to the spectrum of the M-MSNs. The FTIR results of M-MSN-PNIPAAm showed that the absorption peaks at 1640 and 1539 cm 21 were the characteristic absorptions of the CAO (amide I) and NAH (amide II) groups from NIPAAm. The results suggest that the surface of the M-MSNs was successfully coated with PNIPAAm. 44, 45 After the coating with the mesoporous silica layers, a new broad peak of silica appeared at around 2h 5 23 for the M-MSNs. However, the intensity of the characteristic Fe 3 O 4 peaks weakened after the grafting of PNIPAAm onto the outer surface of the M-MSNs. The ordered mesoporous structure of the MMSNs was investigated by small-angle XRD, and the results are shown in Figure 3 39,46 M-MSN-PNIPAAm was proven to be highly sensitive to the magnetic field, and thus, it could serve as a targeting drug-delivery carrier with an external magnetic field.
Loading Efficiency of Sophoridine in M-MSN-PNIPAAm
Sophoridine was used as a model molecule to investigate the loading efficiency of M-MSN-PNIPAAm. The loading 
In Vitro Release and Release Kinetics of M-MSN-PNIPAAm
The in vitro release experiments were carried out at 25 C (below the LCST) and 42 C (above the LCST), respectively. 27, 34 The in vitro release results of sophoridine from M-MSN-PNIPAAm are shown in Figure 7 Subsequently, the release rate gradually slowed down, and the cumulative release amount reached approximately 64.45% at 50 h. However, the release rate was significantly lower at 42 C, and the cumulative release amount of sophoridine from M-MSN-PNIPAAm was only about 25.95% at 50 h. As established, PNIPAAm was sensitive to temperature, with an LCST at about 32 C. 39 Once the solution temperature of M-MSNPNIPAAm was lower than the LCST, the outer layer of the PNIPAAm chains absorbed water, and the solubility state appeared. The soluble PNIPAAm chains resulted in the opening of pore entrances at 25 C. The release of sophoridine from M-MSNPNIPAAm into solutions then became easy. Meanwhile, at 42 C (above the LCST), the PNIPAAM chains shrunk and collapsed toward the surface of the M-MSN-PNIPAAm. 48 Consequently, the pore entrances were blocked, and these significantly obstructed the release amount of sophoridine from the voids of M-MSN-PNIPAAm. Therefore, the release behavior of M-MSNPNIPAAm could be regulated by changes in the external temperature, which controlled the release of drugs.
To evaluate the release mechanism of sophoridine from M-MSN-PNIPAAm, the zero-order, first-order, Higuchi, HixsonCrowell, and Peppas models were used to match the release behaviors. The results of the correlation coefficient (R 2 ) are shown in Table I . The value of R 2 of the Higuchi model was higher than those of the other models at 42 C; this demonstrated that the Higuchi model was the most suitable model for Here, "P" means "transient pressure", "P 0 " means "initial pressure", and "P/P 0 " means "nitrogen partial pressure"; "dV/dD" means "differential calculus of cumulative pore volume and average pore diameter". C for the first and second stages, respectively. The value of n indicates the release mechanism of the Peppas model, for example, n 5 0.43 for typical Fickian diffusion, n 5 0.85 for erosion transport, and 0.43 < n < 0.85 for nontypical Fickian transport. 49 The n values of M-MSN-PNIPAAm were 0.665 and 0.799 for the rapid stages at 25 and 42 C, respectively. The results indicate that nontypical Fickian diffusion was the main release mechanism for M-MSN-PNIPAAm in the first stage.
The n values of M-MSN-PNIPAAm were 0.579 and 0.328 for the second stage at 25 and 42 C, respectively. This showed that nontypical Fickian diffusion was the main release mechanism at 25 C, whereas typical Fickian diffusion was the main release mechanism at 42 C in this stage.
CONCLUSIONS
A novel thermally and magnetically dual-responsive nanocarrier (M-MSN-PNIPAAm) for loading sophoridine was successfully prepared by the incorporation of magnetic nanoparticles, mesoporous silica, and thermally responsive polymers. The PNIPAAm layer on the surface of the MSNs could be reversibly opened and closed as triggered by various temperatures and, thus, could regulate the uptake and release of sophoridine from M-MSN-PNIPAAm. M-MSN-PNIPAAm possessed superparamagnetic properties and could be guided to the target site by external magnetic fields. Therefore, M-MSN-PNIPAAm possesses thermally and magnetically dual-responsive functions for the controlled and targeted release of drugs and shows great application potential for drug-delivery systems. 
